Chaired by Professors Rachel Lennon, Danny Gale, and Neil Turner, this interactive one-day event is dedicated to sharing the latest scientific advances and clinical trials in Alport Syndrome and the achievements and future directions of the Alport Research Hub.   

Morning sessions will showcase the latest scientific advances in Alport Syndrome, while the afternoon programme will feature abstract and poster presentations, as well as updates on current clinical trials from pharmaceutical companies including Bayer, ELOXX and Enyo. 

Expect short talks, interactive networking opportunities, and open discussions as we share the achievements of the Alport Hub to date, give exciting updates for ongoing projects and explore future directions.  

We warmly welcome early career researchers and those who bring new perspectives and partnerships to this growing field.  

Registration and programme available here: https://www.kidneyresearchuk.org/research/information-for-researchers/rare-and-paediatric-kidney-diseases/alport-research-hub/alport-symposium/